123 related articles for article (PubMed ID: 38118143)
1. Structure-Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity.
Zhang Q; Xu B; Chen D; Wu S; Hu X; Zhang X; Yu B; Zhang S; Yang Z; Zhang M; Fang Q
J Med Chem; 2024 Jan; 67(1):272-288. PubMed ID: 38118143
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
[TBL] [Abstract][Full Text] [Related]
3. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
4. Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide.
Li Y; Eans SO; Ganno-Sherwood M; Eliasof A; Houghten RA; McLaughlin JP
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005269
[TBL] [Abstract][Full Text] [Related]
5. OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier Penetration.
Zhang M; Xu B; Li N; Zhang R; Zhang Q; Chen D; Rizvi SFA; Xu K; Shi Y; Yu B; Fang Q
ACS Chem Neurosci; 2022 Nov; 13(21):3078-3092. PubMed ID: 36262082
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
[TBL] [Abstract][Full Text] [Related]
8. All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects.
Zhang M; Xu B; Li N; Zhang Q; Chen D; Wu S; Yu B; Zhang X; Hu X; Zhang S; Jing Y; Yang Z; Jiang J; Fang Q
J Med Chem; 2023 Dec; 66(24):17138-17154. PubMed ID: 38095323
[TBL] [Abstract][Full Text] [Related]
9. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.
Vekariya RH; Lei W; Ray A; Saini SK; Zhang S; Molnar G; Barlow D; Karlage KL; Bilsky EJ; Houseknecht KL; Largent-Milnes TM; Streicher JM; Ananthan S
J Med Chem; 2020 Jul; 63(14):7663-7694. PubMed ID: 32530286
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception.
Zhang M; Xu B; Li N; Liu H; Shi X; Zhang Q; Shi Y; Xu K; Xiao J; Chen D; Zhu H; Sun Y; Zhang T; Zhang R; Fang Q
J Med Chem; 2020 Dec; 63(24):15709-15725. PubMed ID: 33271020
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities.
Wang ZL; Pan JX; Song JJ; Tang HH; Yu HP; Li XH; Li N; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
J Med Chem; 2016 Nov; 59(22):10198-10208. PubMed ID: 27798836
[TBL] [Abstract][Full Text] [Related]
14. Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.
Przydzial MJ; Pogozheva ID; Ho JC; Bosse KE; Sawyer E; Traynor JR; Mosberg HI
J Pept Res; 2005 Nov; 66(5):255-62. PubMed ID: 16218993
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β
Wtorek K; Lipiński PFJ; Adamska-Bartłomiejczyk A; Piekielna-Ciesielska J; Sukiennik J; Kluczyk A; Janecka A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011383
[TBL] [Abstract][Full Text] [Related]
16. Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues.
Anand JP; Porter-Barrus VR; Waldschmidt HV; Yeomans L; Pogozheva ID; Traynor JR; Mosberg HI
Biopolymers; 2014 Jan; 102(1):107-14. PubMed ID: 24436042
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF
Piekielna-Ciesielska J; Mollica A; Pieretti S; Fichna J; Szymaszkiewicz A; Zielińska M; Kordek R; Janecka A
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):560-566. PubMed ID: 29513114
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan Substitution in CJ-15,208 (
Scherrer KH; Eans SO; Medina JM; Senadheera SN; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765026
[TBL] [Abstract][Full Text] [Related]
19. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
20. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
